Evidence map›Paper›PMID 33086499›Full record

ArticleGeriatrics (Basel, Switzerland)2020

Looking for the "Little Things": A Multi-Disciplinary Approach to Medicines Monitoring for Older People Using the ADRe Resource.

David Hughes, Meirion Jordan, Patricia A Logan, Alan Willson, Sherrill Snelgrove, Melanie Storey, Mojtaba Vaismoradi, Sue Jordan

Abstract read
In one paragraph

Article in Geriatrics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. PRN Medicines Optimization and Nurse Education.Pharmacy (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

David HughesFaculty of Health and Life Sciences, Swansea University, Swansea SA2 8PP, UK.
Meirion JordanIndependent Researcher, Swansea SA9 2GA, UK.
Patricia A LoganFaculty of Science, Charles Sturt University, Bathurst 2795, Australia.
Alan WillsonFaculty of Health and Life Sciences, Swansea University, Swansea SA2 8PP, UK.
Sherrill SnelgroveFaculty of Health and Life Sciences, Swansea University, Swansea SA2 8PP, UK.
Melanie StoreyFaculty of Health and Life Sciences, Swansea University, Swansea SA2 8PP, UK.
Mojtaba VaismoradiFaculty of Nursing and Health Sciences, Nord University, 8049 Bodø, Norway.ORCID 0000-0002-5157-4886
Sue JordanFaculty of Health and Life Sciences, Swansea University, Swansea SA2 8PP, UK.ORCID 0000-0002-5691-2987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in medicines have increased the effectiveness of treatments and the social and cultural authority of doctors. However, as prescribing has become the dominant modality of treatment, the "pharmaceuticalization" of medical practice has often resulted in treatment "at a distance", with doctors having limited contact with patients. Older and poorer people, who are socially distanced from medical prescribers, suffer more adverse drug reactions (ADRs) than the general population. A team approach to checking patients systematically for ADRs, as detailed in manufacturers' literature, can minimise medication errors, but regular review is rare. This paper explains the benefits of medicines monitoring to protect older patients from iatrogenic harm, such as over-sedation, falls, or drug-induced Parkinsonism. We show how multidisciplinary initiatives to optimise prescribing can be supported by using a recognised resource-the adverse drug reaction profile (ADRe). The profile identifies and documents patients' signs and symptoms of putative ADRs. Better monitoring allows professionals to adjust prescribing and respond to identified problems with agility. Implementation of systematic monitoring will require changes to the regulatory regime and better inter-professional cooperation. Providing carers, nurses and pharmacists with a structured system to monitor patients would democratise relevant medical knowledge and help address ageism and the socio-economic health divide.

Indexed as

adverse drug reactionscommunity carelong-term caremedicine managementnursingolder people carepatient safety

Identifiers

PMID33086499
PMCPMC7709700

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.